+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Commercial Biotechnology Separation Systems - Global Strategic Business Report

  • PDF Icon

    Report

  • 273 Pages
  • February 2025
  • Region: Global
  • Global Industry Analysts, Inc
  • ID: 3619383
The global market for Commercial Biotechnology Separation Systems was valued at US$26.1 Billion in 2024 and is projected to reach US$31 Billion by 2030, growing at a CAGR of 2.9% from 2024 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.

Global Commercial Biotechnology Separation Systems Market - Key Trends and Drivers Summarized

Commercial biotechnology separation systems are essential for the purification and analysis of biomolecules and proteins, playing a pivotal role in various sectors including pharmaceuticals, agriculture, and energy. These advanced systems have become integral due to continuous developments in separation technologies and a global increase in demand for biopharmaceutical products. The market's growth is buoyed by the rising need for sophisticated separation methods to adhere to stringent Good Manufacturing Practices (GMP) guidelines set by regulatory bodies like the FDA. Recent advancements include the development of systems such as the SFA - Life Sciences Cloud Platform by Sony Corporation and the Octave BIO multi-column chromatography system by Tosoh Bioscience GmbH. These innovations enhance the efficiency of biotechnological separations, catering to evolving industry standards, and support the burgeoning market for biomolecules and proteins.

The adoption and expansion of biotechnology separation systems are driven by several critical factors, ensuring their increasing relevance and utility across the biotechnology field. Notably, the growing prevalence of chronic diseases and the push towards personalized medicine have escalated the demand for biopharmaceuticals, necessitating effective separation systems for therapeutic biomolecule purification. Technological advancements in separation methods, such as enhanced chromatography, filtration, and centrifugation, allow for more efficient handling of complex biological mixtures. Additionally, strict regulatory compliance mandates high purity and quality in biotechnological products, bolstering the need for advanced separation processes. The expansion of the biotechnology sector, especially in emerging markets like the BRIC countries, coupled with significant investments in research and development, further stimulates the need for sophisticated separation technologies.

Emerging trends and drivers such as the introduction of new biologics and the expansion of separation system applications beyond traditional biopharmaceuticals into industries like food, beverage, cosmetics, and agriculture, highlight the broadening scope of biotechnology separation systems. Advances in material science enhance the performance of separation processes, increasing purity levels and yields crucial for biotechnological production. The integration of digital technologies, including IoT, AI, and machine learning, into separation systems streamlines operations, enabling real-time monitoring and optimization of processes. Global health crises have also spotlighted the vital role of separation systems in manufacturing therapeutics and vaccines, emphasizing their importance in pandemic preparedness and response. Lastly, increased funding and venture capital investments are enabling the adoption of cutting-edge separation technologies, fostering innovation and facilitating the acquisition of advanced systems, further driving the market's growth and evolution.

Report Scope

The report analyzes the Commercial Biotechnology Separation Systems market, presented in terms of market value (USD). The analysis covers the key segments and geographic regions outlined below.

Segments

Method (Conventional, Modern); End-Use (Pharmaceutical, Food & Cosmetics, Agriculture, Other End-Uses).

Geographic Regions/Countries

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Key Insights:

  • Market Growth: Understand the significant growth trajectory of the Conventional Method segment, which is expected to reach US$19 Billion by 2030 with a CAGR of a 2.6%. The Modern Method segment is also set to grow at 3.2% CAGR over the analysis period.
  • Regional Analysis: Gain insights into the U.S. market, valued at $7.1 Billion in 2024, and China, forecasted to grow at an impressive 4.8% CAGR to reach $6 Billion by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.

Why You Should Buy This Report:

  • Detailed Market Analysis: Access a thorough analysis of the Global Commercial Biotechnology Separation Systems Market, covering all major geographic regions and market segments.
  • Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
  • Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Commercial Biotechnology Separation Systems Market.
  • Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.

Key Questions Answered:

  • How is the Global Commercial Biotechnology Separation Systems Market expected to evolve by 2030?
  • What are the main drivers and restraints affecting the market?
  • Which market segments will grow the most over the forecast period?
  • How will market shares for different regions and segments change by 2030?
  • Who are the leading players in the market, and what are their prospects?

Report Features:

  • Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2024 to 2030.
  • In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
  • Company Profiles: Coverage of players such as 3M Company, AB Sciex, Agilent Technologies, Inc., Alfa Laval AB, Alfa Wassermann Separation Technologies LLC and more.
  • Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.

Some of the 46 companies featured in this Commercial Biotechnology Separation Systems market report include:

  • 3M Company
  • AB Sciex
  • Agilent Technologies, Inc.
  • Alfa Laval AB
  • Alfa Wassermann Separation Technologies LLC
  • Beckman Coulter Inc.
  • Becton Dickinson and Company
  • Bio-Rad Laboratories Inc.
  • Flottweg SE
  • Fluidigm Corporation
  • GE Healthcare
  • Hitachi High-Technologies Corp.
  • Illumina Inc.
  • Merck KGaA
  • Pall Corporation
  • PerkinElmer Inc.
  • ProMetic Life Sciences Inc.
  • Repligen Corporation
  • Sartorius Stedim Biotech SA
  • Shimadzu Scientific Instruments
  • Sysmex Partec GmbH
  • Thermo Fischer Scientific Inc.

Table of Contents

I. METHODOLOGYII. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
  • Influencer Market Insights
  • Commercial Biotechnology Separation Systems - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
  • Growing Demand for Biopharmaceuticals Spurs Growth of Biotechnology Separation Systems
  • Advancements in Chromatography Techniques Propel Market Growth
  • Increasing Focus on Personalized Medicine Expands Addressable Market Opportunity
  • Technological Innovations in Membrane Filtration Strengthen Business Case for Advanced Separation Systems
  • Government Regulations and Quality Standards Generate Demand for High-Precision Separation Technologies
  • Rising Adoption of Single-Use Technologies Drives Market Adoption
  • Emergence of Continuous Bioprocessing Throws the Spotlight on Efficient Separation Solutions
  • Growing Use of Monoclonal Antibodies Accelerates Demand for Advanced Separation Techniques
  • Increasing Investment in Biotech R&D Sustain Market Growth
  • Adoption of Automation and Robotics in Bioprocessing Fuels Demand for Integrated Separation Systems
  • Expansion of Biosimilars Market Propels Growth of Biotechnology Separation Systems
  • Growing Applications in Cell and Gene Therapy Expand Market Opportunities
  • Impact of Digital Transformation on Process Optimization
  • Increasing Focus on Process Analytical Technology (PAT) Drives Demand for Real-Time Separation Monitoring
  • Challenges in Scale-Up and Commercial Manufacturing Create Opportunities for Modular Solutions
4. GLOBAL MARKET PERSPECTIVE
  • Table 1: World Commercial Biotechnology Separation Systems Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
  • Table 2: World Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • Table 3: World Historic Review for Commercial Biotechnology Separation Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • Table 4: World 15-Year Perspective for Commercial Biotechnology Separation Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
  • Table 5: World Recent Past, Current & Future Analysis for Conventional by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • Table 6: World Historic Review for Conventional by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • Table 7: World 15-Year Perspective for Conventional by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • Table 8: World Recent Past, Current & Future Analysis for Modern by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • Table 9: World Historic Review for Modern by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • Table 10: World 15-Year Perspective for Modern by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • Table 11: World Recent Past, Current & Future Analysis for Pharmaceutical by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • Table 12: World Historic Review for Pharmaceutical by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • Table 13: World 15-Year Perspective for Pharmaceutical by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • Table 14: World Recent Past, Current & Future Analysis for Food & Cosmetics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • Table 15: World Historic Review for Food & Cosmetics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • Table 16: World 15-Year Perspective for Food & Cosmetics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • Table 17: World Recent Past, Current & Future Analysis for Agriculture by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • Table 18: World Historic Review for Agriculture by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • Table 19: World 15-Year Perspective for Agriculture by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • Table 20: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • Table 21: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • Table 22: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
III. MARKET ANALYSIS
UNITED STATES
  • Commercial Biotechnology Separation Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
  • Table 23: USA Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by Method - Conventional and Modern - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • Table 24: USA Historic Review for Commercial Biotechnology Separation Systems by Method - Conventional and Modern Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • Table 25: USA 15-Year Perspective for Commercial Biotechnology Separation Systems by Method - Percentage Breakdown of Value Sales for Conventional and Modern for the Years 2015, 2025 & 2030
  • Table 26: USA Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by End-Use - Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • Table 27: USA Historic Review for Commercial Biotechnology Separation Systems by End-Use - Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • Table 28: USA 15-Year Perspective for Commercial Biotechnology Separation Systems by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses for the Years 2015, 2025 & 2030
CANADA
  • Table 29: Canada Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by Method - Conventional and Modern - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • Table 30: Canada Historic Review for Commercial Biotechnology Separation Systems by Method - Conventional and Modern Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • Table 31: Canada 15-Year Perspective for Commercial Biotechnology Separation Systems by Method - Percentage Breakdown of Value Sales for Conventional and Modern for the Years 2015, 2025 & 2030
  • Table 32: Canada Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by End-Use - Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • Table 33: Canada Historic Review for Commercial Biotechnology Separation Systems by End-Use - Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • Table 34: Canada 15-Year Perspective for Commercial Biotechnology Separation Systems by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses for the Years 2015, 2025 & 2030
JAPAN
  • Commercial Biotechnology Separation Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
  • Table 35: Japan Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by Method - Conventional and Modern - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • Table 36: Japan Historic Review for Commercial Biotechnology Separation Systems by Method - Conventional and Modern Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • Table 37: Japan 15-Year Perspective for Commercial Biotechnology Separation Systems by Method - Percentage Breakdown of Value Sales for Conventional and Modern for the Years 2015, 2025 & 2030
  • Table 38: Japan Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by End-Use - Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • Table 39: Japan Historic Review for Commercial Biotechnology Separation Systems by End-Use - Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • Table 40: Japan 15-Year Perspective for Commercial Biotechnology Separation Systems by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses for the Years 2015, 2025 & 2030
CHINA
  • Commercial Biotechnology Separation Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
  • Table 41: China Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by Method - Conventional and Modern - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • Table 42: China Historic Review for Commercial Biotechnology Separation Systems by Method - Conventional and Modern Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • Table 43: China 15-Year Perspective for Commercial Biotechnology Separation Systems by Method - Percentage Breakdown of Value Sales for Conventional and Modern for the Years 2015, 2025 & 2030
  • Table 44: China Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by End-Use - Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • Table 45: China Historic Review for Commercial Biotechnology Separation Systems by End-Use - Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • Table 46: China 15-Year Perspective for Commercial Biotechnology Separation Systems by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses for the Years 2015, 2025 & 2030
EUROPE
  • Commercial Biotechnology Separation Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
  • Table 47: Europe Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • Table 48: Europe Historic Review for Commercial Biotechnology Separation Systems by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • Table 49: Europe 15-Year Perspective for Commercial Biotechnology Separation Systems by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
  • Table 50: Europe Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by Method - Conventional and Modern - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • Table 51: Europe Historic Review for Commercial Biotechnology Separation Systems by Method - Conventional and Modern Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • Table 52: Europe 15-Year Perspective for Commercial Biotechnology Separation Systems by Method - Percentage Breakdown of Value Sales for Conventional and Modern for the Years 2015, 2025 & 2030
  • Table 53: Europe Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by End-Use - Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • Table 54: Europe Historic Review for Commercial Biotechnology Separation Systems by End-Use - Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • Table 55: Europe 15-Year Perspective for Commercial Biotechnology Separation Systems by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses for the Years 2015, 2025 & 2030
FRANCE
  • Commercial Biotechnology Separation Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
  • Table 56: France Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by Method - Conventional and Modern - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • Table 57: France Historic Review for Commercial Biotechnology Separation Systems by Method - Conventional and Modern Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • Table 58: France 15-Year Perspective for Commercial Biotechnology Separation Systems by Method - Percentage Breakdown of Value Sales for Conventional and Modern for the Years 2015, 2025 & 2030
  • Table 59: France Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by End-Use - Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • Table 60: France Historic Review for Commercial Biotechnology Separation Systems by End-Use - Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • Table 61: France 15-Year Perspective for Commercial Biotechnology Separation Systems by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses for the Years 2015, 2025 & 2030
GERMANY
  • Commercial Biotechnology Separation Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
  • Table 62: Germany Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by Method - Conventional and Modern - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • Table 63: Germany Historic Review for Commercial Biotechnology Separation Systems by Method - Conventional and Modern Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • Table 64: Germany 15-Year Perspective for Commercial Biotechnology Separation Systems by Method - Percentage Breakdown of Value Sales for Conventional and Modern for the Years 2015, 2025 & 2030
  • Table 65: Germany Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by End-Use - Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • Table 66: Germany Historic Review for Commercial Biotechnology Separation Systems by End-Use - Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • Table 67: Germany 15-Year Perspective for Commercial Biotechnology Separation Systems by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses for the Years 2015, 2025 & 2030
ITALY
  • Table 68: Italy Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by Method - Conventional and Modern - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • Table 69: Italy Historic Review for Commercial Biotechnology Separation Systems by Method - Conventional and Modern Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • Table 70: Italy 15-Year Perspective for Commercial Biotechnology Separation Systems by Method - Percentage Breakdown of Value Sales for Conventional and Modern for the Years 2015, 2025 & 2030
  • Table 71: Italy Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by End-Use - Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • Table 72: Italy Historic Review for Commercial Biotechnology Separation Systems by End-Use - Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • Table 73: Italy 15-Year Perspective for Commercial Biotechnology Separation Systems by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses for the Years 2015, 2025 & 2030
UNITED KINGDOM
  • Commercial Biotechnology Separation Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
  • Table 74: UK Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by Method - Conventional and Modern - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • Table 75: UK Historic Review for Commercial Biotechnology Separation Systems by Method - Conventional and Modern Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • Table 76: UK 15-Year Perspective for Commercial Biotechnology Separation Systems by Method - Percentage Breakdown of Value Sales for Conventional and Modern for the Years 2015, 2025 & 2030
  • Table 77: UK Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by End-Use - Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • Table 78: UK Historic Review for Commercial Biotechnology Separation Systems by End-Use - Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • Table 79: UK 15-Year Perspective for Commercial Biotechnology Separation Systems by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses for the Years 2015, 2025 & 2030
SPAIN
  • Table 80: Spain Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by Method - Conventional and Modern - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • Table 81: Spain Historic Review for Commercial Biotechnology Separation Systems by Method - Conventional and Modern Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • Table 82: Spain 15-Year Perspective for Commercial Biotechnology Separation Systems by Method - Percentage Breakdown of Value Sales for Conventional and Modern for the Years 2015, 2025 & 2030
  • Table 83: Spain Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by End-Use - Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • Table 84: Spain Historic Review for Commercial Biotechnology Separation Systems by End-Use - Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • Table 85: Spain 15-Year Perspective for Commercial Biotechnology Separation Systems by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses for the Years 2015, 2025 & 2030
RUSSIA
  • Table 86: Russia Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by Method - Conventional and Modern - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • Table 87: Russia Historic Review for Commercial Biotechnology Separation Systems by Method - Conventional and Modern Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • Table 88: Russia 15-Year Perspective for Commercial Biotechnology Separation Systems by Method - Percentage Breakdown of Value Sales for Conventional and Modern for the Years 2015, 2025 & 2030
  • Table 89: Russia Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by End-Use - Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • Table 90: Russia Historic Review for Commercial Biotechnology Separation Systems by End-Use - Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • Table 91: Russia 15-Year Perspective for Commercial Biotechnology Separation Systems by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses for the Years 2015, 2025 & 2030
REST OF EUROPE
  • Table 92: Rest of Europe Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by Method - Conventional and Modern - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • Table 93: Rest of Europe Historic Review for Commercial Biotechnology Separation Systems by Method - Conventional and Modern Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • Table 94: Rest of Europe 15-Year Perspective for Commercial Biotechnology Separation Systems by Method - Percentage Breakdown of Value Sales for Conventional and Modern for the Years 2015, 2025 & 2030
  • Table 95: Rest of Europe Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by End-Use - Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • Table 96: Rest of Europe Historic Review for Commercial Biotechnology Separation Systems by End-Use - Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • Table 97: Rest of Europe 15-Year Perspective for Commercial Biotechnology Separation Systems by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses for the Years 2015, 2025 & 2030
ASIA-PACIFIC
  • Commercial Biotechnology Separation Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
  • Table 98: Asia-Pacific Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • Table 99: Asia-Pacific Historic Review for Commercial Biotechnology Separation Systems by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • Table 100: Asia-Pacific 15-Year Perspective for Commercial Biotechnology Separation Systems by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
  • Table 101: Asia-Pacific Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by Method - Conventional and Modern - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • Table 102: Asia-Pacific Historic Review for Commercial Biotechnology Separation Systems by Method - Conventional and Modern Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • Table 103: Asia-Pacific 15-Year Perspective for Commercial Biotechnology Separation Systems by Method - Percentage Breakdown of Value Sales for Conventional and Modern for the Years 2015, 2025 & 2030
  • Table 104: Asia-Pacific Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by End-Use - Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • Table 105: Asia-Pacific Historic Review for Commercial Biotechnology Separation Systems by End-Use - Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • Table 106: Asia-Pacific 15-Year Perspective for Commercial Biotechnology Separation Systems by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses for the Years 2015, 2025 & 2030
AUSTRALIA
  • Commercial Biotechnology Separation Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
INDIA
  • Commercial Biotechnology Separation Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
SOUTH KOREAREST OF ASIA-PACIFIC
LATIN AMERICA
  • Commercial Biotechnology Separation Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
ARGENTINABRAZILMEXICOREST OF LATIN AMERICA
MIDDLE EAST
  • Commercial Biotechnology Separation Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
IRANISRAELSAUDI ARABIAUNITED ARAB EMIRATESREST OF MIDDLE EAST
AFRICA
  • Commercial Biotechnology Separation Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
IV. COMPETITION

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • 3M Company
  • AB Sciex
  • Agilent Technologies, Inc.
  • Alfa Laval AB
  • Alfa Wassermann Separation Technologies LLC
  • Beckman Coulter Inc.
  • Becton Dickinson and Company
  • Bio-Rad Laboratories Inc.
  • Flottweg SE
  • Fluidigm Corporation
  • GE Healthcare
  • Hitachi High-Technologies Corp.
  • Illumina Inc.
  • Merck KGaA
  • Pall Corporation
  • PerkinElmer Inc.
  • ProMetic Life Sciences Inc.
  • Repligen Corporation
  • Sartorius Stedim Biotech SA
  • Shimadzu Scientific Instruments
  • Sysmex Partec GmbH
  • Thermo Fischer Scientific Inc.

Table Information